Tag: CDK inhibitor

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to CDK inhibitor

Lilly's Verzenio Extends Five-Year Breast Cancer Survival, Adds to Debate Over Best CDK4 ...

Added to Collection on: 2022-09-11 00:27:34

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Piperazines
Cyclopentanes
Breakthrough therapy
Pyridines
Palbociclib
Ribociclib
CDK inhibitor
Abemaciclib
Letrozole

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's two advanced breast cancer trials meet primary endpoints - PMLiVE

Added to Collection on: 2022-10-26 11:46:21

Tags for this article:

Chemical compounds
Organic compounds
Protein kinase inhibitors
Breast cancer
Quinazolines
Metastatic breast cancer
HER2/neu
Cyclin-dependent kinase 4
CDK inhibitor
Palbociclib
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca hails survival rates of breast cancer drugs - Morningstar

Added to Collection on: 2022-10-26 09:09:09

Tags for this article:

Chemical compounds
Organic compounds
Health
Breast cancer
RTT
Metastatic breast cancer
Monoclonal antibodies
Clinical endpoint
Durvalumab
CDK inhibitor
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
TOP NEWS: AstraZeneca hails survival rates of breast cancer drugs - shareprices.com

Added to Collection on: 2022-10-26 08:48:52

Tags for this article:

Chemical compounds
Health
Organic compounds
Breast cancer
RTT
Metastatic breast cancer
Monoclonal antibodies
Clinical endpoint
Durvalumab
CDK inhibitor
AstraZeneca plc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca: Capivasertib Phase III Trial Meets Primary Goals - RTTNews

Added to Collection on: 2022-10-26 23:42:07

Tags for this article:

Chemical compounds
Organic compounds
Drugs
Protein kinase inhibitors
AstraZeneca
Piperazines
Medical terminology
Progression-free survival
Quinazolines
Fulvestrant
CDK inhibitor
Palbociclib
AstraZeneca plc
AZN.L
Faslodex

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's new drug improves survival chances in patients with advanced ER-positive ...

Added to Collection on: 2022-10-26 19:55:44

Tags for this article:

Drugs
Chemical compounds
Medicine
Breast cancer
AstraZeneca
Metastatic breast cancer
Protein kinase inhibitors
Fulvestrant
Progression-free survival
Estrogen
CDK inhibitor
Breast cancer management

Click the tags to see associated articles and topics

View Article Details
BioNTech SE Stock Up Momentum With A 9% Rise At Session Start On Tuesday | Via News

Added to Collection on: 2022-12-13 15:58:40

Tags for this article:

Breast cancer
Triple-negative breast cancer
Protein kinase inhibitors
AXL receptor tyrosine kinase
CDK inhibitor
BioNTech SE

Click the tags to see associated articles and topics

View Article Details
SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis - Nature

Added to Collection on: 2022-12-27 10:19:18

Tags for this article:

Branches of biology
Cell cycle
Biology
Proteins
Cell biology
Cyclin-dependent kinase 2
Cyclin
Small interfering RNA
ATM serine/threonine kinase
RNA-dependent RNA polymerase
CDK inhibitor

Click the tags to see associated articles and topics

View Article Details
Arvinas falls 17% after early-stage data for Pfizer-partnered tumor therapy - Seeking Alpha

Added to Collection on: 2023-01-09 19:48:22

Tags for this article:

Chemical compounds
Organic compounds
Branches of biology
Protein kinase inhibitors
Cell cycle
Cyclopentanes
Piperazines
Specialty drugs
Palbociclib
HER2/neu
Cyclin-dependent kinase
CDK inhibitor
Pfizer
arvinas

Click the tags to see associated articles and topics

View Article Details
Palbociclib by Pfizer for Mantle Cell Lymphoma: Likelihood of Approval

Added to Collection on: 2023-12-26 17:13:01

Tags for this article:

Aminopyridines
Breast cancer
Lactams
Palbociclib
HER2
Fulvestrant
Metastatic breast cancer
Chemotherapy regimen
Transitional cell carcinoma
CDK inhibitor
Abemaciclib
PD-0332991
Pfizer

Click the tags to see associated articles and topics

View Article Details